References
- Cercenado E, Sanchez-Carrillo C, Alcala L, Bouza E y Grupo de Trabajo para el Estudio de Estafilococcos. SituaciOn actual de la resistencia de Staphylococccus en Espana. Rev Clin Esp 1997; 197, suppl 2: 12-18.
- Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. MIVIWR 1995; 44, RR-12: 1-13.
- Circulation 1984; 70: 1123–1124.
- Periti P, Donati L. Survival and therapy of burn patients at the threshold of the twenty-first century: a review. J Chemother 1995; 7 (6): 475–502.
- Donati L, Periti P. Antibiotic treatment of burned patients: an Italian multicentre study. Intensive Care Med 1994; 20:S30–S34.
- Periti P, Donati L. Ruolo attuale della vancomicina nella chemioterapia antimicrobica delle gravi ustioni. Farm Ter 1995; XII (suppl 2): 5-36.
- Boucher BA, Kuhl DA; Hickerson WL. Pharmacokinetics of systemically administered antibiotics in patients with thermal injury. Clin Infect Dis 1992; 14: 458–463.
- Steer JA, Papini RPG, Wilson APR et al. Pharmacokinetics of a single dose of teicoplanin in burn patients. J Antimicrob Chemother 1996; 37: 545–553.
- Garrelts JC, Peterie JD: Altered vancomycin dose vs. serum concentration relationship in burn patients. Clin Pharmacol Ther 1988; 44: 9–13.
- Rybak MJ, Albrecht LM, Berman JR, Warbasse LH, Svensson CK. Vancomycin pharmacokinetics in burn patients and intravenous drug abusers. Antimicrob Agents Chemother 1990; 34 (5): 792–795.
- Wilson APR, Gruneberg RN, Neu H. Dosage recom-mendations for teicoplanin. J Antimicrob Chemother 1993; 32: 792–796.
- Young EJ. Prevention of infection in prosthetic joints. Curr Opin Infect Dis 1990; 3: 666–669.
- Periti P, Mini E, Mosconi G. Antimicrobial prophylaxis in orthopedic surgery: the role of teicoplanin. J Antimicrob Chemother, in press, 1997.